Please login to the form below

Not currently logged in
Email:
Password:

Edelman wins AZ oncology porfolio

Edelman has won AstraZeneca's entire oncology portfolio, including Casodex and Zoladex.

The PR agency won the business against short-listed agency Cohn & Wolfe. Industry sources suggest the account could be worth up to £500,000. Edelman has previously worked on rival pharma firm Pfizer's oncology business.

The win follows AstraZeneca's decision to consolidate its oncology portfolio within one agency. The company had been using Axon Communications, Porter Novelli, Virgo Health PR and Cohn & Wolfe for individual cancer products. The latest additions to its cancer product range are Faslodex and Iressa.

AstraZeneca's head of communications, global marketing, Louise Fairburn said: "We have a number of PR directors working on the portfolio, and over time we have had a number of PR agencies, which didn't make sense."

She added: "We have a strong brand focus but not for the portfolio as a whole. This is an attempt to build a really strong global alliance in communications."

Edelman European health practice chair, Carolyn Paul, will head up the account. Fairburn will be the main point of contact for the agency.

Virgo will continue to handle the global support for Faslodex and Arimidex until quarter two next year when the accounts will be transferred to Edelman.

9th November 2009

Share

Subscribe to our email news alerts

Featured jobs

PMHub

Add my company
Lucid Group Communications Limited

WE’RE ON A MISSION To transform lives through communication that changes behaviour and improves health outcomes....

Latest intelligence

Is communication failing us?
Compelling people to care in a world oversaturated with news and information...
Are your field teams ready to excel in the new era?
A qualitative research approach to help you critically assess post-pandemic learnings and ignite the potential of meaningful interactions with HCPs....
5 Healthcare Marketing Blunders | How To Avoid Them.
Here are 5 healthcare marketing blunders and how best to avoid them....